| 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 566 | 2023 |
| Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF JJV McMurray, AM Jackson, CSP Lam, MM Redfield, IS Anand, J Ge, ... Circulation 141 (5), 338-351, 2020 | 343 | 2020 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 236 | 2019 |
| Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ... European heart journal 38 (9), 648-660, 2017 | 232 | 2017 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 168 | 2017 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 139 | 2018 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 111 | 2020 |
| Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score M Tokodi, WR Schwertner, A Kovács, Z Tősér, L Staub, A Sárkány, ... European heart journal 41 (18), 1747-1756, 2020 | 105 | 2020 |
| Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary B Merkely, AJ Szabó, A Kosztin, E Berényi, A Sebestyén, C Lengyel, ... Geroscience 42, 1063-1074, 2020 | 94 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 91 | 2020 |
| Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure … V Kutyifa, L Geller, P Bogyi, E Zima, MK Aktas, EE Ozcan, D Becker, ... European journal of heart failure 16 (12), 1323-1330, 2014 | 70 | 2014 |
| Quantification of the relative contribution of the different right ventricular wall motion components to right ventricular ejection fraction: the ReVISION method B Lakatos, Z Tősér, M Tokodi, A Doronina, A Kosztin, D Muraru, ... Cardiovascular Ultrasound 15, 1-9, 2017 | 68 | 2017 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 60 | 2022 |
| Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial B Merkely, A Kosztin, A Roka, L Geller, E Zima, A Kovacs, AM Boros, ... Ep Europace 19 (9), 1549-1555, 2017 | 56 | 2017 |
| De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis A Kosztin, M Vamos, D Aradi, WR Schwertner, A Kovacs, KV Nagy, ... Heart failure reviews 23, 15-26, 2018 | 50 | 2018 |
| Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry CJ Kapelios, C Laroche, MG Crespo‐Leiro, SD Anker, AJS Coats, ... European journal of heart failure 22 (8), 1424-1437, 2020 | 47 | 2020 |
| Contemporary management of severe symptomatic aortic stenosis M Eugène, P Duchnowski, B Prendergast, O Wendler, C Laroche, ... Journal of the American College of Cardiology 78 (22), 2131-2143, 2021 | 44 | 2021 |
| Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration … CJ Kapelios, M Lainscak, G Savarese, C Laroche, P Seferovic, ... European journal of heart failure 21 (11), 1383-1397, 2019 | 43 | 2019 |
| Dominance of free wall radial motion in global right ventricular function of heart transplant recipients BK Lakatos, M Tokodi, A Assabiny, Z Tősér, A Kosztin, A Doronina, ... Clinical Transplantation 32 (3), e13192, 2018 | 37 | 2018 |
| Role of right ventricular global longitudinal strain in predicting early and long-term mortality in cardiac resynchronization therapy patients VK Nagy, G Széplaki, A Apor, V Kutyifa, A Kovács, A Kosztin, D Becker, ... PloS one 10 (12), e0143907, 2015 | 35 | 2015 |
Béla MerkelyProfessor of Cardiology, Heart Center, Semmelweis University在 kardio.sote.hu 的电子邮件经过验证
